{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:19:59Z","timestamp":1790518799411,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T00:00:00Z","timestamp":1410998400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s13023-014-0129-1","type":"journal-article","created":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T14:27:08Z","timestamp":1410964028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Clinical efficacy of Enzyme Replacement Therapy in paediatric Hunter patients, an independent study of 3.5 years"],"prefix":"10.1186","volume":"9","author":[{"given":"Rosella","family":"Tomanin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"D\u2019Avanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Rampazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Gasparotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Parini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Pascarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Concolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Procopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Fiumara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Borgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Chiara","family":"Frigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,18]]},"reference":[{"key":"129_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ejhg.2011.143","volume":"20","author":"M Beck","year":"2012","unstructured":"Beck M, Wijburg FA, Gal A: Clinical utility gene card for: mucopolysaccharidosis type II. Eur J Hum Genet. 2012, 20: 1-10.1038\/ejhg.2011.143. doi:10.1038\/ejhg.2011.143. Epub 2011 Aug 24,","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"129_CR2","doi-asserted-by":"publisher","first-page":"e377","DOI":"10.1542\/peds.2007-1350","volume":"121","author":"R Martin","year":"2008","unstructured":"Martin R, Beck M, Eng C, Giugliani R, Harmatz P, Munoz V, Muenzer J: Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics. 2008, 121 (2): e377-e386. 10.1542\/peds.2007-1350.","journal-title":"Pediatrics"},{"key":"129_CR3","first-page":"3421","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J, et al: The mucopolysaccharidoses. The Metabolic and Molecular Bases of Inherited Disease. Edited by: Scriver CR, Beaudet AL, Sly WS. 2001, McGraw-Hill, New York, NY, USA, 3421-3452. 8","edition":"8"},{"issue":"6","key":"129_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/jmg.19.6.408","volume":"19","author":"ID Young","year":"1982","unstructured":"Young ID, Harper PS, Newcombe RG, Archer IM: A clinical and genetic study of Hunter's syndrome. 2. Differences between the mild and severe forms. J Med Genet. 1982, 19 (6): 408-411. 10.1136\/jmg.19.6.408.","journal-title":"J Med Genet"},{"issue":"3","key":"129_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s10545-011-9317-5","volume":"34","author":"R Manara","year":"2011","unstructured":"Manara R, Priante E, Grimaldi M, Santoro L, Astarita L, Barone R, Concolino D, Di Rocco M, Donati MA, Fecarotta S, Ficcadenti A, Fiumara A, Furlan F, Giovannini I, Lilliu F, Mardari R, Polonara G, Procopio E, Rampazzo A, Rossi A, Sanna G, Parini R, Scarpa M: Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy. J Inherit Metab Dis. 2011, 34 (3): 763-780. 10.1007\/s10545-011-9317-5.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"129_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF00711387","volume":"18","author":"GV Coppa","year":"1995","unstructured":"Coppa GV, Gabrielli O, Zampini L, Jetzequel AM, Miniero R, Busca A, De Luca T, Di Natale P: Bone marrow transplantation in Hunter syndrome. J Inherit Metab Dis. 1995, 18 (1): 91-92. 10.1007\/BF00711387.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"129_CR7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jpeds.2008.11.041","volume":"154","author":"N Guffon","year":"2009","unstructured":"Guffon N, Bertrand Y, Forest I, Fouilhoux A, Froissart R: Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years. J Pediatr. 2009, 154 (5): 733-737. 10.1016\/j.jpeds.2008.11.041.","journal-title":"J Pediatr"},{"issue":"2","key":"129_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ymgme.2013.11.015","volume":"111","author":"J Muenzer","year":"2014","unstructured":"Muenzer J: Early initiation of enzyme replacement therapy for the mucopolysaccharidoses. Mol Genet Metab. 2014, 111 (2): 63-72. 10.1016\/j.ymgme.2013.11.015.","journal-title":"Mol Genet Metab"},{"issue":"8","key":"129_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","volume":"8","author":"J Muenzer","year":"2006","unstructured":"Muenzer J, Wraith JE, Beck M, Giugliani R, Harmatz P, Eng CM, Vellodi A, Martin R, Ramaswami U, Gucsavas-Calikoglu M, Vijayaraghavan S, Wendt S, Puga AC, Ulbrich B, Shinawi M, Cleary M, Piper D, Conway AM, Kimura A: A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med. 2006, 8 (8): 465-473. 10.1097\/01.gim.0000232477.37660.fb.","journal-title":"Genet Med"},{"issue":"3","key":"129_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","volume":"90","author":"J Muenzer","year":"2007","unstructured":"Muenzer J, Gucsavas-Calikoglu M, McCandless SE, Schuetz TJ, Kimura A: A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Mol Genet Metab. 2007, 90 (3): 329-337. 10.1016\/j.ymgme.2006.09.001.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"129_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ejmg.2010.07.013","volume":"53","author":"C Alcalde-Martin","year":"2010","unstructured":"Alcalde-Martin C, Muro-Tudelilla JM, Cancho-Candela R, Gutierrez-Solana LG, Pintos-Morell G, Marti-Herrero M, Munguira-Aguado P, Galan-Gomez E: First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS). Eur J Med Genet. 2010, 53 (6): 371-377. 10.1016\/j.ejmg.2010.07.013.","journal-title":"Eur J Med Genet"},{"issue":"2","key":"129_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/GIM.0b013e318206786f","volume":"13","author":"J Muenzer","year":"2011","unstructured":"Muenzer J, Beck M, Giugliani R, Suzuki Y, Tylki-Szymanska A, Valayannopoulos V, Vellodi A, Wraith JE: Idursulfase treatment of Hunter syndrome in children younger than 6 years: results from the Hunter Outcome Survey. Genet Med. 2011, 13 (2): 102-109. 10.1097\/GIM.0b013e318206786f.","journal-title":"Genet Med"},{"issue":"6","key":"129_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/gim.2013.162","volume":"16","author":"R Giugliani","year":"2014","unstructured":"Giugliani R, Hwu WL, Tylki-Szymanska A, Whiteman DA, Pano A: A multicenter, open-label study evaluating safety and clinical outcomes in children (1.4-7.5 years) with Hunter syndrome receiving idursulfase enzyme replacement therapy. Genet Med. 2014, 16 (6): 435-441. 10.1038\/gim.2013.162.","journal-title":"Genet Med"},{"key":"129_CR14","doi-asserted-by":"crossref","unstructured":"Lampe C, Atherton A, Burton BK, Descartes M, Giugliani R, Horovitz DD, Kyosen SO, Magalhaes TS, Martins AM, Mendelsohn NJ, Muenzer J, Smith LD: Enzyme Replacement Therapy in Mucopolysaccharidosis II Patients Under 1 Year of Age.JIMD Rep 2014, Epub ahead of print.,","DOI":"10.1007\/8904_2013_289"},{"issue":"39","key":"129_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta16390","volume":"16","author":"K Wyatt","year":"2012","unstructured":"Wyatt K, Henley W, Anderson L, Anderson R, Nikolaou V, Stein K, Klinger L, Hughes D, Waldek S, Lachmann R, Mehta A, Vellodi A, Logan S: The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders. Health Technol Assess. 2012, 16 (39): 1-543.","journal-title":"Health Technol Assess"},{"key":"129_CR16","unstructured":"Vellodi A, Wraith JE, Chakrapani A, Hendriksz C, Jones S, Lavery C: Mucopolysaccharidosis type II: Guidelines for Assessment, Monitoring and Enzyme Replacement Therapy (ERT) - MPS II guidelines Version II - reviewed 2010. []., [http:\/\/www.webarchive.org.uk\/wayback\/archive\/20130328002531\/http:\/\/www.specialisedservices.nhs.uk\/library\/23\/Guidelines_for_Mucopolysaccharidosis_Type_II.pdf]"},{"key":"129_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","volume":"26","author":"CJ Clopper","year":"1934","unstructured":"Clopper CJ, Pearson ES: The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934, 26: 404-10.1093\/biomet\/26.4.404.","journal-title":"Biometrika"},{"issue":"7","key":"129_CR18","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","volume":"16","author":"WA Zoghbi","year":"2003","unstructured":"Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003, 16 (7): 777-802. 10.1016\/S0894-7317(03)00335-3.","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"129_CR19","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/sim.4780111005","volume":"11","author":"TJ Cole","year":"1992","unstructured":"Cole TJ, Green PJ: Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med. 1992, 11 (10): 1305-1319. 10.1002\/sim.4780111005.","journal-title":"Stat Med"},{"issue":"6","key":"129_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/adc.2007.123653","volume":"93","author":"AE Lammers","year":"2008","unstructured":"Lammers AE, Hislop AA, Flynn Y, Haworth SG: The 6-minute walk test: normal values for children of 4-11 years of age. Arch Dis Child. 2008, 93 (6): 464-468. 10.1136\/adc.2007.123653.","journal-title":"Arch Dis Child"},{"issue":"2","key":"129_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","volume":"13","author":"J Muenzer","year":"2011","unstructured":"Muenzer J, Beck M, Eng CM, Giugliani R, Harmatz P, Martin R, Ramaswami U, Vellodi A, Wraith JE, Cleary M, Gucsavas-Calikoglu M, Puga AC, Shinawi M, Ulbrich B, Vijayaraghavan S, Wendt S, Conway AM, Rossi A, Whiteman DA, Kimura A: Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome. Genet Med. 2011, 13 (2): 95-101. 10.1097\/GIM.0b013e3181fea459.","journal-title":"Genet Med"},{"key":"129_CR22","volume-title":"GeneReviews","author":"M Scarpa","year":"1993","unstructured":"Scarpa M: Mucopolysaccharidosis Type II. GeneReviews. Edited by: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP. 1993, University of Washington, Seattle, Seattle (WA)"},{"key":"129_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1750-1172-6-72","volume":"6","author":"M Scarpa","year":"2011","unstructured":"Scarpa M, Almassy Z, Beck M, Bodamer O, Bruce IA, De Meirleir L, Guffon N, Guillen-Navarro E, Hensman P, Jones S, Kamin W, Kampmann C, Lampe C, Lavery CA, Teles EL, Link B, Lund AM, Malm G, Pitz S, Rothera M, Stewart C, Tylki-Szymanska A, Van der Ploeg A, Walker R, Zeman J, Wraith JE: Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet J Rare Dis. 2011, 6: 72-1172. 10.1186\/1750-1172-6-72.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"129_CR24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10545-011-9280-1","volume":"34","author":"E Glamuzina","year":"2011","unstructured":"Glamuzina E, Fettes E, Bainbridge K, Crook V, Finnegan N, Abulhoul L, Vellodi A: Treatment of mucopolysaccharidosis type II (Hunter syndrome) with idursulfase: the relevance of clinical trial end points. J Inherit Metab Dis. 2011, 34 (3): 749-754. 10.1007\/s10545-011-9280-1.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"129_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jpeds.2011.01.054","volume":"159","author":"C Kampmann","year":"2011","unstructured":"Kampmann C, Beck M, Morin I, Loehr JP: Prevalence and characterization of cardiac involvement in Hunter syndrome. J Pediatr. 2011, 159 (2): 327-331. 10.1016\/j.jpeds.2011.01.054. e2","journal-title":"J Pediatr"},{"issue":"2","key":"129_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1017\/S1047951109003576","volume":"19","author":"V Fesslova","year":"2009","unstructured":"Fesslova V, Corti P, Sersale G, Rovelli A, Russo P, Mannarino S, Butera G, Parini R: The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses. Cardiol Young. 2009, 19 (2): 170-178. 10.1017\/S1047951109003576.","journal-title":"Cardiol Young"},{"issue":"2","key":"129_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10545-011-9444-z","volume":"36","author":"MM Brands","year":"2013","unstructured":"Brands MM, Frohn-Mulder IM, Hagemans ML, Hop WC, Oussoren E, Helbing WA, van der Ploeg AT: Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI. J Inherit Metab Dis. 2013, 36 (2): 227-234. 10.1007\/s10545-011-9444-z.","journal-title":"J Inherit Metab Dis"},{"issue":"455","key":"129_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1651-2227.2007.00212.x","volume":"96","author":"IV Schwartz","year":"2007","unstructured":"Schwartz IV, Ribeiro MG, Mota JG, Toralles MB, Correia P, Horovitz D, Santos ES, Monlleo IL, Fett-Conte AC, Sobrinho RP, Norato DY, Paula AC, Kim CA, Duarte AR, Boy R, Valadares E, De Michelena M, Mabe P, Martinhago CD, Pina-Neto JM, Kok F, Leistner-Segal S, Burin MG, Giugliani R: A clinical study of 77 patients with mucopolysaccharidosis type II. Acta Paediatr Suppl. 2007, 96 (455): 63-70. 10.1111\/j.1651-2227.2007.00212.x.","journal-title":"Acta Paediatr Suppl"},{"issue":"3","key":"129_CR29","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1651-2227.2010.02060.x","volume":"100","author":"A Rozdzynska","year":"2011","unstructured":"Rozdzynska A, Tylki-Szymanska A, Jurecka A, Cieslik J: Growth pattern and growth prediction of body height in children with mucopolysaccharidosis type II. Acta Paediatr. 2011, 100 (3): 456-460. 10.1111\/j.1651-2227.2010.02060.x.","journal-title":"Acta Paediatr"},{"issue":"7","key":"129_CR30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/GIM.0b013e31817701e6","volume":"10","author":"JE Wraith","year":"2008","unstructured":"Wraith JE, Beck M, Giugliani R, Clarke J, Martin R, Muenzer J: Initial report from the Hunter Outcome Survey. Genet Med. 2008, 10 (7): 508-516. 10.1097\/GIM.0b013e31817701e6.","journal-title":"Genet Med"},{"issue":"1","key":"129_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ymgme.2013.03.001","volume":"109","author":"SA Jones","year":"2013","unstructured":"Jones SA, Parini R, Harmatz P, Giugliani R, Fang J, Mendelsohn NJ: The effect of idursulfase on growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS). Mol Genet Metab. 2013, 109 (1): 41-48. 10.1016\/j.ymgme.2013.03.001.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"129_CR32","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1111\/j.1651-2227.2011.02522.x","volume":"101","author":"J Marucha","year":"2012","unstructured":"Marucha J, Jurecka A, Syczewska M, Rozdzynska-Swiatkowska A, Tylki-Szymanska A: Restricted joint range of motion in patients with MPS II: correlation with height, age and functional status. Acta Paediatr. 2012, 101 (4): e183-e188. 10.1111\/j.1651-2227.2011.02522.x.","journal-title":"Acta Paediatr"},{"issue":"11","key":"129_CR33","first-page":"CD008185","volume":"11","author":"EM Da Silva","year":"2011","unstructured":"Da Silva EM, Strufaldi MW, Andriolo RB, Silva LA: Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome). Cochrane Database Syst Rev. 2011, 11 (11): CD008185-","journal-title":"Cochrane Database Syst Rev"},{"key":"129_CR34","first-page":"CD008185","volume":"1","author":"EM Da Silva","year":"2014","unstructured":"Da Silva EM, Strufaldi MW, Andriolo RB, Silva LA: Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome). Cochrane Database Syst Rev. 2014, 1: CD008185-","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"129_CR35","doi-asserted-by":"publisher","first-page":"e1258","DOI":"10.1542\/peds.2010-1274","volume":"127","author":"JB Holt","year":"2011","unstructured":"Holt JB, Poe MD, Escolar ML: Natural progression of neurological disease in mucopolysaccharidosis type II. Pediatrics. 2011, 127 (5): e1258-e1265. 10.1542\/peds.2010-1274.","journal-title":"Pediatrics"},{"issue":"6","key":"129_CR36","doi-asserted-by":"publisher","first-page":"e1228","DOI":"10.1542\/peds.2008-0999","volume":"124","author":"J Muenzer","year":"2009","unstructured":"Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Koseoglu ST, Link B, Martin RA, Molter DW, Munoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E: Multidisciplinary management of Hunter syndrome. Pediatrics. 2009, 124 (6): e1228-e1239. 10.1542\/peds.2008-0999.","journal-title":"Pediatrics"},{"issue":"3","key":"129_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","volume":"167","author":"JE Wraith","year":"2008","unstructured":"Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N, Meldgaard Lund A, Malm G, Van der Ploeg AT, Zeman J: Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr. 2008, 167 (3): 267-277. 10.1007\/s00431-007-0635-4.","journal-title":"Eur J Pediatr"},{"key":"129_CR38","doi-asserted-by":"publisher","first-page":"c6471","DOI":"10.1136\/bmj.c6471","volume":"341","author":"JC Roos","year":"2010","unstructured":"Roos JC, Hyry HI, Cox TM: Orphan drug pricing may warrant a competition law investigation. BMJ. 2010, 341: c6471-10.1136\/bmj.c6471.","journal-title":"BMJ"},{"issue":"42","key":"129_CR39","first-page":"1172","volume":"6","author":"S Simoens","year":"2011","unstructured":"Simoens S: Pricing and reimbursement of orphan drugs: the need for more transparency. Orphanet J Rare Dis. 2011, 6 (42): 1172-1176.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"129_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00431-011-1606-3","volume":"171","author":"J Muenzer","year":"2012","unstructured":"Muenzer J, Bodamer O, Burton B, Clarke L, Frenking GS, Giugliani R, Jones S, Rojas MV, Scarpa M, Beck M, Harmatz P: The role of enzyme replacement therapy in severe Hunter syndrome-an expert panel consensus. Eur J Pediatr. 2012, 171 (1): 181-188. 10.1007\/s00431-011-1606-3.","journal-title":"Eur J Pediatr"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0129-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-014-0129-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0129-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0129-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T05:39:58Z","timestamp":1630561198000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-014-0129-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,18]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["129"],"URL":"https:\/\/doi.org\/10.1186\/s13023-014-0129-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,18]]},"assertion":[{"value":"7 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"129"}}